Carregant...
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways
BACKGROUND: Despite recent advances in diagnosis and treatment, prostate cancer (PCa) remains the leading cause of cancer-related deaths in men. Current treatments offered in the clinics are often toxic and have severe side effects. Hence, to treat and manage PCa, new agents with fewer side effects...
Guardat en:
| Publicat a: | World J Surg Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001031/ https://ncbi.nlm.nih.gov/pubmed/29898731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-018-1400-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|